|
|
Exchange: |
New York Stock Exchange |
Security
Type: |
Common |
Shares
Out: |
1,430,000,000 |
Market
Cap: |
104.26(B) |
Last
Volume: |
15,276,394 |
Avg
Vol: |
8,465,245 |
52
Week Range: |
$48.64 - $68.84 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Health Services |
Level
III Sector: |
Medical Instruments & Supplies |
|
Member Indexes:
|
S&P COMPOSITE 1500 |
|
NYSE COMPOSITE |
|
S&P 500 |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : 297 |
Guru Rank Value : 4.1 |
Guru Occurances : 2 |
|
|
|
|
|
|
|
Company Profile Boston Scientific develops, manufactures and markets medical devices. Co.'s Medical Surgical segment consist of: Endoscopy, which develops and manufactures devices to diagnose and treat a range of gastrointestinal and pulmonary conditions; and Urology and Pelvic Health, which develops and manufactures devices to treat various urological and pelvic conditions. Co.'s Rhythm and Neuro segment includes: Cardiac Rhythm Management, which develops and manufactures implantable devices to treat cardiac abnormalities; and Electrophysiology, which develops and manufactures medical technologies used in the diagnosis and treatment of rate and rhythm disorders of the heart.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
86,763 |
367,796 |
891,893 |
1,852,495 |
Total Sell Value |
$5,815,387 |
$21,391,604 |
$49,075,093 |
$90,475,166 |
Total People Sold |
6 |
8 |
11 |
13 |
Total Sell Transactions |
9 |
19 |
36 |
69 |
End Date |
2024-01-25 |
2023-10-24 |
2023-04-25 |
2022-04-25 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Lance Jean Fitterer |
SVP, Asst GC, Bus & Regions |
|
2015-02-16 |
4 |
D |
$14.98 |
$23,099 |
D/D |
(1,542) |
117,174 |
|
- |
|
Lance Jean Fitterer |
SVP, Asst GC, Bus & Regions |
|
2015-02-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,588 |
118,716 |
|
- |
|
Fitzgerald Joseph Michael |
EVP & President, CRM |
|
2015-02-10 |
4 |
S |
$14.66 |
$897,450 |
D/D |
(61,208) |
84,379 |
|
- |
|
Pierce David A |
SVP and President, Endoscopy |
|
2015-02-09 |
4 |
AS |
$14.66 |
$73,301 |
D/D |
(5,000) |
28,161 |
|
- |
|
Ballinger Kevin J. |
SVP & Pres, Interven Cardio |
|
2015-02-06 |
4 |
S |
$15.06 |
$322,360 |
D/D |
(21,408) |
28,440 |
|
- |
|
Thepaut Eric Francis Yves |
SVP & Pres, EuropeOfficer |
|
2015-01-24 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
83,334 |
|
- |
|
Phalen Michael P. |
EVP & President, MedSurg |
|
2015-01-20 |
4 |
AS |
$14.54 |
$145,407 |
D/D |
(10,000) |
108,645 |
|
- |
|
Pierce David A |
SVP and President, Endoscopy |
|
2015-01-08 |
4 |
AS |
$14.31 |
$266,327 |
D/D |
(18,612) |
33,161 |
|
- |
|
Phalen Michael P. |
EVP & President, MedSurg |
|
2015-01-08 |
4 |
AS |
$14.31 |
$394,782 |
D/D |
(27,589) |
118,645 |
|
- |
|
Phalen Michael P. |
EVP & President, MedSurg |
|
2015-01-05 |
4 |
AS |
$13.75 |
$137,500 |
D/D |
(10,000) |
146,234 |
|
- |
|
Bose Supratim |
EVP & President, Asia-Pacific |
|
2015-01-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
14,925 |
78,610 |
|
- |
|
Nicholas Peter M |
Director |
|
2015-01-02 |
4 |
A |
$0.00 |
$0 |
D/D |
3,971 |
3,462,549 |
|
- |
|
Onuscheck John Michael |
SVP & President, Europe |
|
2015-01-01 |
4 |
D |
$13.25 |
$178,941 |
D/D |
(13,505) |
116,025 |
|
- |
|
Onuscheck John Michael |
SVP & President, Europe |
|
2015-01-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
25,875 |
129,530 |
|
- |
|
Phalen Michael P. |
EVP & President, MedSurg |
|
2015-01-01 |
4 |
D |
$13.25 |
$183,009 |
D/D |
(13,812) |
156,234 |
|
- |
|
Phalen Michael P. |
EVP & President, MedSurg |
|
2015-01-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
41,401 |
170,046 |
|
- |
|
Pierce David A |
SVP and President, Endoscopy |
|
2015-01-01 |
4 |
D |
$13.25 |
$93,929 |
D/D |
(7,089) |
51,773 |
|
- |
|
Pierce David A |
SVP and President, Endoscopy |
|
2015-01-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
20,701 |
58,862 |
|
- |
|
Lance Jean Fitterer |
SVP, Asst GC, Bus & Regions |
|
2015-01-01 |
4 |
D |
$13.25 |
$119,926 |
D/D |
(9,051) |
114,128 |
|
- |
|
Lance Jean Fitterer |
SVP, Asst GC, Bus & Regions |
|
2015-01-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
25,875 |
123,179 |
|
- |
|
Dawkins Keith D |
EVP, Global Chief Med. Off. |
|
2015-01-01 |
4 |
D |
$13.25 |
$138,118 |
D/D |
(10,424) |
143,188 |
|
- |
|
Dawkins Keith D |
EVP, Global Chief Med. Off. |
|
2015-01-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
31,050 |
153,612 |
|
- |
|
Brennan Daniel J. |
EVP and CFO |
|
2015-01-01 |
4 |
D |
$13.25 |
$77,036 |
D/D |
(5,814) |
105,882 |
|
- |
|
Brennan Daniel J. |
EVP and CFO |
|
2015-01-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
16,819 |
111,696 |
|
- |
|
Mirviss Jeffrey B. |
SVP&Pres, Periph Intervent |
|
2015-01-01 |
4 |
D |
$13.25 |
$73,829 |
D/D |
(5,572) |
79,622 |
|
- |
|
2007 Records found
|
|
Page 7 of 81 |
|
|